Mitochondrial Modulator M1 Attenuates Ovarian Aging By Remodeling Granulosa Cell Metabolism And Improving Oocyte Maturation
As women age, their fertility naturally declines, a process known as ovarian aging. A key factor in this decline is the health of the cells surrounding the eggs, called granulosa cells, and the eggs themselves, known as oocytes. These cells rely heavily on tiny powerhouses within them, called mitochondria, to produce the energy needed for proper function and development.
With age, these mitochondria can become dysfunctional, leading to a shift in how granulosa cells produce energy. Instead of efficiently generating energy through a process called oxidative phosphorylation, they tend to rely more on a less efficient method called glycolysis. This metabolic change contributes to poorer egg quality and reduced fertility.
Recent research has shed light on a fascinating way ovarian cells communicate and share these vital mitochondria. They do so through tiny bridges called tunneling nanotubes. However, this crucial sharing process significantly decreases as ovaries age.
A new study explored ways to restore this vital mitochondrial communication. Researchers found that by using a specific modulator, they could enhance the formation of these tunneling nanotubes and boost the transfer of mitochondria between cells. This intervention successfully restored energy production (ATP levels), improved mitochondrial health, and reactivated efficient energy production in aged cells.
Furthermore, growing ovarian cells in a special 3D environment that mimics the body’s natural tissue also helped improve mitochondrial function. When tested in aged mice, this modulator increased the number of healthy egg-containing follicles, improved the quality of the oocytes’ mitochondria, and raised levels of a hormone indicating ovarian reserve.
These findings suggest a promising new strategy to combat reproductive aging by enhancing the natural ability of ovarian cells to share and rejuvenate their mitochondria, potentially offering new avenues for fertility treatments.
Source: link to paper